Q&A Automated, localized, fast: why a top apparel leader is getting behind unspun’s fabric tech By Milo Werner
Snapshot Kanvas Bio speeds the search for microbiome therapies through industrial-scale imaging of gut and host cells By Jason Pontin
Company Profile Flexible Power for an inflexible grid: Why DCVC backed Mainspring Energy By Milo Werner
Company Profile Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits By Dr. Emily Park, Dr. Kiersten Stead
Company Profile Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners By Dr. Justin Kern
News DCVC joins $100 million seed round to power Callosum, builder of a new orchestration layer for heterogeneous AI By Jason Pontin
News When the incumbent joins the insurgent: Former Cummins CEO takes the helm at Mainspring By Milo Werner
News A bold and timely bet: the U.S. Government invests in quantum computing By Matthew Ocko, James Hardiman, Dr. Prineha Narang
Commentary Winning the quantum race: America’s blueprint for dominating the next tech revolution By Dr. Prineha Narang
Thoughts Professor Prineha Narang joins DCVC as we double down on our historical quantum tech leadership By Matthew Ocko, Zachary Bogue
Deep Tech Opportunities Report DCVC publishes the 2026 Deep Tech Opportunities report: “Back to Fundamentals in an Age of Exponential Change” By Matthew Ocko, Zachary Bogue
Deep Tech Opportunities Report Deep Tech Opportunity: Startup-built technologies are bringing us new ways to dominate in the air and in space
Deep Tech Opportunities Report Deep Tech Opportunity: There’s an exciting new way to put protein-like drugs inside cells
Deep Tech Opportunities Report Deep Tech Opportunity: It’s time to develop better drugs to treat anxiety